Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Öykü Dinç"'
Homologous or heterologous COVID-19 vaccine schemes: comparison of immune responses and side effects
Autor:
Karaali, Rıdvan, Öykü Dinç, Harika Öykü, İnanç Balkan, İlker, Can, Günay, Keskin, Elif, Çolak, Hatice, Daşdemir, Ferhat Osman, Aydoğan, Okan, Budak, Beyhan, Kaya, Sibel Yildiz, Kocazeybek, Bekir, Saltoğlu, Neşe
Publikováno v:
In Diagnostic Microbiology & Infectious Disease October 2023 107(2)
Autor:
Harika Öykü Dinç, Mehmet Demirci, Yusuf Emre Özdemir, Serhat Sirekbasan, Ayse Nur Aktaş, Rıdvan Karaali, Yeşim Tuyji Tok, Doğukan Özbey, Rüveyda Akçin, Nesrin Gareayaghi, Mert Ahmet Kuşkucu, Kenan Midilli, Gökhan Aygün, Suat Sarıbaş, Bekir Kocazeybek
Publikováno v:
Balkan Medical Journal, Vol 39, Iss 3, Pp 172-177 (2022)
Background: Monitoring the longevity of immunoglobulin G (IgG) responses following severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infections is vital to understanding the role of antibodies in preventing infection. Aims: To determine t
Externí odkaz:
https://doaj.org/article/3857eb3b877148e9b59b0d697d7433d2
Autor:
Toraman, Gülbahar Özge Alim, Atasoy, Sezen, Şenol, Halil, Şükran Okudan, Emine, Öykü Dinç, Harika, Topçu, Gülaçtı
Publikováno v:
Chemistry & Biodiversity; Oct2024, Vol. 21 Issue 10, p1-22, 22p
Publikováno v:
Experimed. 12:215-218
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a9eb7ff4e1c46561bcc9df3009fa70e8
https://doi.org/10.26650/experimed.1191760
https://doi.org/10.26650/experimed.1191760
Autor:
Nesrin Gareayaghi GAREAYAGHİ, Harika Öykü DİNÇ, Doğukan ÖZBEY, Rüveyda AKÇİN, Ferhat Osman DAŞDEMİR, Seher AKKUS, Önder Yüksel ERYİĞİT, Bekir KOCAZEYBEK
Publikováno v:
Volume: 19, Issue: 3 576-580
Journal of Harran University Medical Faculty
Harran Üniversitesi Tıp Fakültesi Dergisi
Journal of Harran University Medical Faculty
Harran Üniversitesi Tıp Fakültesi Dergisi
Background: Currently, many immunological test methods are used to evaluate the humoral immune response after COVID-19 vaccination or infection. In our study, we aimed to evaluate the SARS-CoV-2 humoral immune response in people who had implemented C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b11f9996567093c275a8f67cd38ffc4
https://doi.org/10.35440/hutfd.1138445
https://doi.org/10.35440/hutfd.1138445
Autor:
Reyhan ÇALIŞKAN, Silva Polat SARI, Betül BÜYÜKKILIÇ ALTINBAŞAK, Harika Öykü DİNÇ, Aleyna BALEKOĞLU, Ghassan ISSA, Pelin YÜKSEL MAYDA
Publikováno v:
Bezmialem Science. 10:796-804
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bb32c30fc6162452dd2be851ee60c1b0
https://doi.org/10.14235/bas.galenos.2022.84803
https://doi.org/10.14235/bas.galenos.2022.84803
Autor:
Melih Tütüncü, Serkan Demir, Gökhan Arslan, Öykü Dinç, Sedat Şen, Tuncay Gündüz, Cihat Uzunköprü, Haluk Gümüş, Mesude Tütüncü, Rüveyda Akçin, Serkan Özakbaş, Mesrure Köseoğlu, Sena Destan Bünül, Ozan Gezen, Damla Çetinkaya Tezer, Cavid Baba, Pınar Acar Özen, Rabia Koç, Tuğrul Elverdi, Uğur Uygunoğlu, Murat Kürtüncü, Yeşim Beckmann, İpek Güngör Doğan, Ömer Faruk Turan, Cavit Boz, Murat Terzi, Asli Tuncer, Sabahattin Saip, Rana Karabudak, Bekir Kocazeybek, Hüsnü Efendi, Uğur Bilge, Aksel Siva
Background: COVID-19 vaccines are recommended for people with multiple sclerosis (pwMS). Adequate humoral responses are obtained in pwMS receiving disease-modifying therapies (DMTs) after vaccination, with the exception of those receiving B-cell-depl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f1944fc2585d69f26fdff210c2db9d0
https://avesis.deu.edu.tr/publication/details/e5b3fb6b-a010-478f-a08d-7bdb7bdc68dd/oai
https://avesis.deu.edu.tr/publication/details/e5b3fb6b-a010-478f-a08d-7bdb7bdc68dd/oai
Autor:
Yeşim Tuyji Tok, Harika Öykü Dinç, Rüveyda Akçin, Ferhat Osman Daşdemir, Önder Yüksel Eryiğit, Mehmet Demirci, Nesrin Gareayaghi, Mert Ahmet Kuşkucu, Bekir Sami Kocazeybek
Publikováno v:
Mikrobiyoloji Bulteni. 56:251-262
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::011b8939fe8f9544d94a51d3671593cf
https://doi.org/10.5578/mb.20229805
https://doi.org/10.5578/mb.20229805
Günümüzde kansere ve diğer mikroorganizmalara karşı kullanılan ilaçların pek çoğunun biyoyararlanımının düşük olması ve başta toksisite gibi yan etkilerinden dolayı tedavide yeni ilaçların varlığına ihtiyaç duyulmaktadır. H
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::201fedc2efa42ec4541378298a819736
https://hdl.handle.net/20.500.12645/37091
https://hdl.handle.net/20.500.12645/37091
Autor:
Harika Öykü Dinç, Nuran Karabulut, Sema Alaçam, Hayriye Kırkoyun Uysal, Ferhat Osman Daşdemir, Mustafa Önel, Yeşim Tuyji Tok, Serhat Sirekbasan, Ali Agacfidan, Nesrin Gareayaghi, Hüseyin Çakan, Önder Yüksel Eryiğit, Bekir Kocazeybek
Publikováno v:
Diagnostics
Volume 13
Issue 5
Pages: 972
Volume 13
Issue 5
Pages: 972
This study aimed to evaluate the performance characteristics of a rapid antigen test developed to detect SARS-CoV-2 (COVID-19), influenza A virus (IAV), and influenza B virus (IBV) (flu) compared with those of the real-time reverse transcription-poly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8dcc8c0fc157f738cf82e660fe1d18c1
https://hdl.handle.net/20.500.13055/409
https://hdl.handle.net/20.500.13055/409